Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enqiang Liu

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Thescientificworldjournal|July 1, 2014
A game-theoretical approach to multimedia social networks securityEnqiang Liu, Zengliang Liu, Fei Shao, et al.
Oncotarget|October 6, 2017
MicroRNA-18a promotes proliferation and metastasis in hepatocellular carcinoma via targeting KLF4Li Liu, Xun Cai, Enqiang Liu, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 31, 2014
Nedaplatin or oxaliplatin combined with paclitaxel and docetaxel as first-line treatment for patients with advanced non-small cell lung cancerKeqian Zhang, Hong Qin, Feng Pan, et al.
Bioorganic Chemistry|January 29, 2026
Design, synthesis, and biological evaluation of novel HDAC3 PROTACs for combined therapy with Venetoclax in acute myeloid leukemiaYuxin Chen, Enqiang Liu, Xingchun Ding, et al.
European Journal of Medicinal Chemistry|July 24, 2024
Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemiaEnqiang Liu, Yuxin Chen, Mengting Qin, et al.
Gene Therapy|July 6, 2018
Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinomaChuan Tian, Haixia Wu, Chan Li, et al.
Journal of Medicinal Chemistry|April 7, 2025
Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related DiseasesKairui Yue, Simin Sun, Zequn Yin, et al.
European Journal of Medicinal Chemistry|January 15, 2024
HDAC/NAMPT dual inhibitors overcome initial drug-resistance in p53-null leukemia cellsKairui Yue, Simin Sun, Enqiang Liu, et al.
Journal of Medicinal Chemistry|November 11, 2025
Design, Synthesis, and Anti-inflammatory Activity Evaluation for Hydrazide-Based HDAC6 Targeted Protein DegradersSimin Sun, Kairui Yue, Enqiang Liu, et al.
Journal of Nanobiotechnology|July 25, 2023
Recent advance in phytonanomedicine and mineral nanomedicine delivery system of the treatment for acute myeloid leukemiaYimin Jia, Cun Sun, Ting Chen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Thescientificworldjournal|July 1, 2014
A game-theoretical approach to multimedia social networks securityEnqiang Liu, Zengliang Liu, Fei Shao, et al.
Oncotarget|October 6, 2017
MicroRNA-18a promotes proliferation and metastasis in hepatocellular carcinoma via targeting KLF4Li Liu, Xun Cai, Enqiang Liu, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 31, 2014
Nedaplatin or oxaliplatin combined with paclitaxel and docetaxel as first-line treatment for patients with advanced non-small cell lung cancerKeqian Zhang, Hong Qin, Feng Pan, et al.
Bioorganic Chemistry|January 29, 2026
Design, synthesis, and biological evaluation of novel HDAC3 PROTACs for combined therapy with Venetoclax in acute myeloid leukemiaYuxin Chen, Enqiang Liu, Xingchun Ding, et al.
European Journal of Medicinal Chemistry|July 24, 2024
Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemiaEnqiang Liu, Yuxin Chen, Mengting Qin, et al.
Gene Therapy|July 6, 2018
Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinomaChuan Tian, Haixia Wu, Chan Li, et al.
Journal of Medicinal Chemistry|April 7, 2025
Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related DiseasesKairui Yue, Simin Sun, Zequn Yin, et al.
European Journal of Medicinal Chemistry|January 15, 2024
HDAC/NAMPT dual inhibitors overcome initial drug-resistance in p53-null leukemia cellsKairui Yue, Simin Sun, Enqiang Liu, et al.
Journal of Medicinal Chemistry|November 11, 2025
Design, Synthesis, and Anti-inflammatory Activity Evaluation for Hydrazide-Based HDAC6 Targeted Protein DegradersSimin Sun, Kairui Yue, Enqiang Liu, et al.
Journal of Nanobiotechnology|July 25, 2023
Recent advance in phytonanomedicine and mineral nanomedicine delivery system of the treatment for acute myeloid leukemiaYimin Jia, Cun Sun, Ting Chen, et al.
Pageof 2